Home › Funds › CPP Investments › AMPH
CPP Investments position in AMPH
AMPHASTAR PHARMACEUTICALS IN · Health Care
Latest position (Q2 2026)11.50K sh
Reported value held$232.07K
Portfolio Weight0.00%
First reportedQ4 2024
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 100 | $3.71K | New |
| Q1 2025 | 2.70K | $78.27K | Add |
| Q2 2025 | 4.20K | $96.43K | Add |
| Q3 2025 | 20.70K | $551.65K | Add |
| Q4 2025 | 29.80K | $798.04K | Add |
| Q1 2026 | 16.30K | $319.32K | Reduce |
| Q2 2026 | 11.50K | $232.07K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AMPH
- Vanguard Group 2.61M sh · $69.85M · Q4 2025
- Marshall Wace 1.07M sh · $21.52M · Q2 2026
- Geode Capital Management 969.84K sh · $19.58M · Q2 2026
- D. E. Shaw & Co 887.05K sh · $17.90M · Q2 2026
- Renaissance Technologies 525.10K sh · $10.60M · Q2 2026
- Goldman Sachs Group 505.36K sh · $10.20M · Q2 2026
- UBS Group AG 393.11K sh · $7.93M · Q2 2026
- Northern Trust Corp 370.99K sh · $7.49M · Q2 2026
- Charles Schwab Investment Management 310.18K sh · $6.26M · Q2 2026
- BlackRock Inc 6.83M sh · $6.19M · Q2 2026
- Royce & Associates 294.76K sh · $5.95M · Q2 2026
- Two Sigma Investments 248.12K sh · $5.01M · Q2 2026